<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In <z:hpo ids='HP_0001396'>cholestasis</z:hpo>, serum <z:chebi fb="23" ids="18059">lipids</z:chebi> are altered </plain></SENT>
<SENT sid="1" pm="."><plain>The alterations could at least partially be ascribed to the occurrence of an abnormal <z:chebi fb="1" ids="6495">lipoprotein</z:chebi>, LP-X </plain></SENT>
<SENT sid="2" pm="."><plain>In 103 patients with <z:hpo ids='HP_0000952'>jaundice</z:hpo>, out of whom 16 had extra-hepatic <z:hpo ids='HP_0001396'>cholestasis</z:hpo>, the presence of LP-X was tested and semi-quantificated (by visual grading) utilizing an immunological technique </plain></SENT>
<SENT sid="3" pm="."><plain>In extra-hepatic <z:hpo ids='HP_0001396'>cholestasis</z:hpo>, <z:hpo ids='HP_0000001'>all</z:hpo> patients showed LP-X in serum, while in intra-hepatic drug-induced <z:hpo ids='HP_0001396'>cholestasis</z:hpo> 87% revealed this phenomenon </plain></SENT>
<SENT sid="4" pm="."><plain>At the initial stage of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo>, in drug-induced <z:hpo ids='HP_0001396'>cholestasis</z:hpo>, and in extra-hepatic <z:hpo ids='HP_0001396'>cholestasis</z:hpo>, the semi-quantificated LP-X correlated with alkaline phosphatase values </plain></SENT>
<SENT sid="5" pm="."><plain>In extra-hepatic <z:hpo ids='HP_0001396'>cholestasis</z:hpo>, LP-X disappeared soon after the obstruction was relieved by operation </plain></SENT>
</text></document>